Where Will Kestra Medical Stock Be in 1 Year?
Kestra Medical Technologies (NASDAQ:KMTS) is a medical device startup that…
Buy
78
IDT Quote, Financials, Valuation and Earnings
Last price:
$66.42
Seasonality move
:
1.21%
Day range:
$64.23 - $66.11
52-week range:
$33.84 - $69.67
Dividend yield:
0.33%
P/E ratio:
17.43x
P/S ratio:
1.37x
P/B ratio:
5.83x
Volume:
235.8K
Avg. volume:
234.7K
1-year change:
86.06%
Market cap:
$1.7B
Revenue:
$1.2B
EPS (TTM):
$3.79
Analysts' Opinion
-
Consensus RatingIDT has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $85.60, IDT has an estimated upside of 29.56% from its current price of $66.07.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $85.60 representing 100% downside risk from its current price of $66.07.
Fair Value
-
According to the consensus of 1 analyst, IDT has 29.56% upside to fair value with a price target of $85.60 per share.
IDT vs. S&P 500
-
Over the past 5 trading days, IDT has underperformed the S&P 500 by -0.71% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
IDT does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
IDT has grown year-over-year revenues for 5 quarters straight. In the most recent quarter IDT reported revenues of $302M.
Earnings Growth
-
IDT has grown year-over-year earnings for 4 quarters straight. In the most recent quarter IDT reported earnings per share of $0.86.
Enterprise value:
1.5B
EV / Invested capital:
4.72x
Price / LTM sales:
1.37x
EV / EBIT:
14.94x
EV / Revenue:
1.20x
PEG ratio (5yr expected):
0.10x
EV / Free cash flow:
14.58x
Price / Operating cash flow:
16.64x
Enterprise value / EBITDA:
12.33x
Gross Profit (TTM):
$433.9M
Return On Assets:
17.16%
Net Income Margin (TTM):
7.85%
Return On Equity:
34.57%
Return On Invested Capital:
34.57%
Operating Margin:
8.94%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-04-30 | 2024-04-30 | 2025-04-30 | 2024-04-30 | 2025-04-30 | |
| Income Statement | ||||||
| Revenue | $1.3B | $1.2B | $1.2B | $299.6M | $302M | |
| Gross Profit | $353.2M | $378.7M | $433.9M | $97M | $112M | |
| Operating Income | $65.3M | $56.9M | $98.2M | $12.3M | $27M | |
| EBITDA | $85.1M | $77.3M | $119M | $17.4M | $32.2M | |
| Diluted EPS | $1.93 | $1.40 | $3.79 | $0.22 | $0.86 | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $354M | $371.1M | $390M | $408.5M | $498.3M | |
| Total Assets | $461.9M | $503.3M | $518.2M | $517.3M | $600.9M | |
| Current Liabilities | $327.3M | $315.4M | $301.7M | $277.8M | $287.2M | |
| Total Liabilities | $334.7M | $327M | $308.8M | $283.2M | $290.1M | |
| Total Equity | $127.2M | $176.3M | $209.5M | $234.1M | $310.9M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-04-30 | 2024-04-30 | 2025-04-30 | 2024-04-30 | 2025-04-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $44.8M | $78.2M | $121.5M | $9.5M | $75.7M | |
| Cash From Investing | -$33.9M | -$8.6M | -$10.1M | -$3.2M | -$492K | |
| Cash From Financing | -$23.2M | -$18M | -$27.2M | -$5.3M | -$7.9M | |
| Free Cash Flow | $20.7M | $58.7M | $100.7M | $4.7M | $70.3M | |
IDT
Sector
Market Cap
$1.7B
$84.8M
Price % of 52-Week High
94.83%
67.46%
Dividend Yield
0.33%
0%
Shareholder Yield
2.13%
3.76%
1-Year Price Total Return
86.06%
-7.14%
Beta (5-Year)
0.717
0.583
Dividend yield:
0.33%
Annualized payout:
$0.10
Payout ratio:
5.52%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$66.00
200-day SMA
Buy
Level
$49.59
Bollinger Bands (100)
Buy
Level
46.86 - 59.6
Chaikin Money Flow
Buy
Level
66.5M
20-day SMA
Buy
Level
$63.68
Relative Strength Index (RSI14)
Buy
Level
60.57
ADX Line
Buy
Level
41.13
Williams %R
Neutral
Level
-28.754
50-day SMA
Buy
Level
$57.38
MACD (12, 26)
Buy
Level
2.41
25-day Aroon Oscillator
Buy
Level
12
On Balance Volume
Neutral
Level
86.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.1405)
Buy
CA Score
(Annual)
Level (0.5647)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.3309)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.
Stock Forecast FAQ
In the current month, IDT has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IDT average analyst price target in the past 3 months is $85.60.
-
Where Will IDT Stock Be In 1 Year?
According to analysts, the consensus estimate is that IDT share price will rise to $85.60 per share over the next 12 months.
-
What Do Analysts Say About IDT?
Analysts are divided on their view about IDT share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that IDT is a Sell and believe this share price will drop from its current level to $85.60.
-
What Is IDT's Price Target?
The price target for IDT over the next 1-year time period is forecast to be $85.60 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is IDT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for IDT is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of IDT?
You can purchase shares of IDT via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase IDT shares.
-
What Is The IDT Share Price Today?
IDT was last trading at $66.42 per share. This represents the most recent stock quote for IDT. Yesterday, IDT closed at $66.07 per share.
-
How To Buy IDT Stock Online?
In order to purchase IDT stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Howard Marks Buy Grab Stock?
When a legendary value investor who cut his teeth in…
Why Did Warren Buffett Buy Amazon Stock?
When investors think of tech stocks in Warren Buffett’s portfolio,…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
88
CDTX alert for Jun 24
Cidara Therapeutics [CDTX] is up 3.18% over the past day.
Sell
46
HIMS alert for Jun 24
Hims & Hers Health [HIMS] is up 2.26% over the past day.
Buy
67
WGS alert for Jun 24
GeneDx Holdings [WGS] is up 13.99% over the past day.
